OpenBilldrug price receipt

NADAC week of 2026-10-14

VALACYCLOVIR HCL 1 GRAM TABLET

For 30 tablets

Pharmacies pay

$12.30 filed

30 × $0.41001 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$23.86 filed

30 × $0.79548 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

1.9× estimated

Medicare paid 1.9× what pharmacies pay.

Part D averages every strength and form sold under “Valacyclovir” / “Valacyclovir HCl” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$19.15 estimated

$12.30 + $1.85 (15%) + $5.00 fee per fill = $19.15

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

VALACYCLOVIR HCL 1 GRAM TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as “valacyclovir” and “valacyclovir hydrochloride”, as its NDCs’ listings variously write the nonproprietary name.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 11 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., NorthStar Rx LLC and Camber Pharmaceuticals, Inc.

FDA lists it under 3 Established Pharmacologic Classes: Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor, Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor and Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor.

The NADAC file of 2026-10-14 prices it under 23 NDCs (National Drug Codes); the FDA directory lists 18 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $12.30 for 30 tablets (30 × $0.41001 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 11 labelers

LabelerNDCsPharmacies pay per unit
Camber Pharmaceuticals, Inc.3$0.41001 per EA filed
Aurobindo Pharma Limited2$0.41001 per EA filed
Chartwell RX, LLC2$0.41001 per EA filed
Mylan Pharmaceuticals Inc.2$0.41001 per EA filed
Rising Pharma Holdings, Inc.2$0.41001 per EA filed
Westminster Pharmaceuticals, LLC2$0.41001 per EA filed
American Health Packaging1$0.41001 per EA filed
AvPAK1$0.41001 per EA filed
NorthStar Rx LLC1$0.41001 per EA filed
Quallent Pharmaceuticals Health LLC1$0.41001 per EA filed
SUN PHARMACEUTICAL INDUSTRIES, INC.1$0.41001 per EA filed
Not listed as a package in the FDA directory5$0.41001 per EA filed
All 23 NDCs, with labeler and price
  • 00378-4276-77 · Mylan Pharmaceuticals Inc. · $0.41001 per EA · eff. 2026-09-23 filed
  • 00378-4276-93 · Mylan Pharmaceuticals Inc. · $0.41001 per EA · eff. 2026-09-23 filed
  • 16714-0697-03 · NorthStar Rx LLC · $0.41001 per EA · eff. 2026-09-23 filed
  • 31722-0705-05 · Camber Pharmaceuticals, Inc. · $0.41001 per EA · eff. 2026-09-23 filed
  • 31722-0705-30 · Camber Pharmaceuticals, Inc. · $0.41001 per EA · eff. 2026-09-23 filed
  • 31722-0705-90 · Camber Pharmaceuticals, Inc. · $0.41001 per EA · eff. 2026-09-23 filed
  • 50268-0789-11 · not listed as a package in the FDA directory · $0.41001 per EA · eff. 2026-09-23 filed
  • 50268-0789-15 · AvPAK · $0.41001 per EA · eff. 2026-09-23 filed
  • 57237-0043-30 · Rising Pharma Holdings, Inc. · $0.41001 per EA · eff. 2026-09-23 filed
  • 57237-0043-90 · Rising Pharma Holdings, Inc. · $0.41001 per EA · eff. 2026-09-23 filed
  • 62135-0614-30 · Chartwell RX, LLC · $0.41001 per EA · eff. 2026-09-23 filed
  • 62135-0614-90 · Chartwell RX, LLC · $0.41001 per EA · eff. 2026-09-23 filed
  • 63304-0905-90 · SUN PHARMACEUTICAL INDUSTRIES, INC. · $0.41001 per EA · eff. 2026-09-23 filed
  • 65862-0449-30 · Aurobindo Pharma Limited · $0.41001 per EA · eff. 2026-09-23 filed
  • 65862-0449-90 · Aurobindo Pharma Limited · $0.41001 per EA · eff. 2026-09-23 filed
  • 68084-0309-11 · not listed as a package in the FDA directory · $0.41001 per EA · eff. 2026-09-23 filed
  • 68084-0309-21 · American Health Packaging · $0.41001 per EA · eff. 2026-09-23 filed
  • 69097-0154-02 · not listed as a package in the FDA directory · $0.41001 per EA · eff. 2026-09-23 filed
  • 69097-0154-05 · not listed as a package in the FDA directory · $0.41001 per EA · eff. 2026-09-23 filed
  • 69097-0154-12 · not listed as a package in the FDA directory · $0.41001 per EA · eff. 2026-09-23 filed
  • 69367-0263-09 · Westminster Pharmaceuticals, LLC · $0.41001 per EA · eff. 2026-09-23 filed
  • 69367-0263-30 · Westminster Pharmaceuticals, LLC · $0.41001 per EA · eff. 2026-09-23 filed
  • 82009-0041-90 · Quallent Pharmaceuticals Health LLC · $0.41001 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share an FDA nonproprietary name with VALACYCLOVIR HCL 1 GRAM TABLET.

ProductPharmacies pay per unitMedicare per unit
VALACYCLOVIR HCL 1 GRAM TABLET this page
generic · tablet, film coated / tablet
$0.41001 per EA filed
eff. 2026-09-23
$0.79548 per EA filed
Part D 2024 average
VALACYCLOVIR HCL 500 MG TABLET
generic · tablet, film coated / tablet
$0.22889 per EA filed
eff. 2026-09-23
$0.79548 per EA filed
Part D 2024 average
VALTREX 1 GRAM CAPLET
brand · tablet, film coated
$20.244 per EA filed
eff. 2026-05-20
$16.36915 per EA filed
Part D 2024 average
VALTREX 500 MG CAPLET
brand · tablet, film coated
$12.80513 per EA filed
eff. 2026-05-20
$16.36915 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-05-20, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 23 NDCs’ NADAC prices is $0.41001 per EA filed.

Of the 6 other products in FDA’s Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor class priced per EA, 2 have a higher middle NADAC price and 4 a lower one. The one in the middle is ACYCLOVIR 800 MG TABLET, at $0.19403 per EA filed (eff. 2026-09-23).

Of the 6 other products in FDA’s Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor class priced per EA, 2 have a higher middle NADAC price and 4 a lower one. The one in the middle is ACYCLOVIR 800 MG TABLET, at $0.19403 per EA filed (eff. 2026-09-23).

Of the 9 other products in FDA’s Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor class priced per EA, 4 have a higher middle NADAC price and 5 a lower one. The one in the middle is VALACYCLOVIR HCL 500 MG TABLET, at $0.22889 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $23.86 for 30 tablets, at an average of $0.79548 per EA in 2024 (2024-01-01 to 2024-12-31) for “Valacyclovir” and “Valacyclovir HCl”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 3,299,119 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for VALACYCLOVIR HCL 1 GRAM TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Valacyclovir / Valacyclovir HCl: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.